Transforming Prostate Cancer Care

In the realm of Molecular Oncology, Professor Zodwa Dlamini stands as a dedicated force, unwavering in her commitment to advancing precision oncology in Africa. At the heart of her career is the pivotal role as the Founding Director of the Pan African Cancer Research Institute (PACRI). Holding additional prestigious positions such as Director of the SAMRC Precision Oncology Research Unit (PORU) and DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Professor Dlamini demonstrates full dedication to advancing precision medicine in the ongoing battle against cancer. Beyond institutional leadership, she serves as a distinguished member of the American Association for Cancer Research (AACR) Regional Advisory Committee on Sub-Saharan Africa. In this capacity, she actively guides the AACR Pathology Resources in Africa Advisory Group, identifying strategies to address gaps in cancer pathology services across the African continent. The exceptional work in the field has earned Professor Dlamini the esteemed appointment as a distinguished Cancer Immunology Jury Member for the prestigious 2024 Innovators in Science Award. Sponsored by Takeda and administered by the New York Academy of Sciences, this accolade recognizes ground-breaking research in Cancer Immunology on a global scale. Her role on the jury affords her the privilege of providing invaluable input and guidance to the selection process, contributing a unique global perspective. Notably, Professor Dlamini is the Guest Editor and a member of the Editorial Advisory Committee (EAC) for the 2023 edition of the South African Health Review (SAHR), a special edition focusing on fortifying cancer services in South Africa. Her contributions also extend to the African Organization for Research and Training in Cancer (AORTIC), where she actively influences the organization's strategic direction and mission as a member of the Research Committee Scientific Advisory Board. The recognition of Professor Dlamini's dedication to advancing cancer research in Africa culminated in a Special Award from the Council and Executive of the African Society of Morphology, leading to her admission as an "Honorary Fellow" of the West African College of Morphologists. Moreover, she holds the esteemed titles of an Overseas Fellow of the Royal Society of Medicine (London), a Professional Member of the New York Academy of Sciences (USA), and a member of the Academy of Science of South Africa. These affiliations underscore her significant contributions to the field of Science. Through her multifaceted efforts, Professor Zodwa Dlamini remains steadfast in her commitment to shaping the ever-evolving landscape of cancer research. Her journey is driven by an unshakable belief that cancer can be conquered, paving the way for a healthier and more equitable world.

Part I. Understanding Prostate Cancer.- Chapter 1. The Evolving Landscape of Prostate Cancer Care.- Chapter 2. Understanding Prostate Cancer: Pathogenesis, Risk Factors, and Early Detection.- Part II. Diagnostic Advances and Precision Medicine.- Chapter 3. Diagnostic Advances: Innovative Techniques and Biomarkers for Prostate Cancer Diagnosis.- Chapter 4. Genomic Discoveries: Precision Medicine and Personalized Approaches in Prostate Cancer Care.- Part III. Innovative Treatment Strategies.- Chapter 5. Targeted Therapies: Novel Treatment Strategies for Prostate Cancer.- Chapter 6. Immunotherapy and Prostate Cancer: Harnessing the Immune System for Treatment.- Chapter 7. Radiopharmaceuticals and Radiotherapy: Advances in Radiation-Based Therapies.- Chapter 8. Prostate Cancer Surgical Innovations: Evolution from Open to Minimally Invasive Techniques.- Chapter 9. Managing Advanced Prostate Cancer: Breakthroughs in Hormone Therapy and Beyond.- Part IV. Comprehensive Patient Care and Future Outlook.- Chapter 10. Integrative Care: Supporting Patients through Complementary and Lifestyle Approaches.- Chapter 11. Survivorship and Quality of Life: Addressing the Physical and Emotional Well-being of Prostate Cancer Patients.- Chapter 12. Translational Research: Bridging the Gap between Bench and Bedside.- Chapter 13. Conclusion: Navigating the Future of Prostate Cancer Care.